Bizizz Market Research has recently published a research report, “Hyperkalemia Treatment Market By disease (Acute Hyperkalemia and Chronic Hyperkalemia), Drug (Sodium zirconium cyclosilicate, Patriomer, Beta2 Agonist, Diuretics, Sodium Polystyrene Sulfonate and Others), Component, and Region-Global Industry Trends, Estimation & Forecast, 2019 – 2027”.
As per the report, Global Hyperkalemia Treatment Market was valued at US$ XX Bn in 2018 and it is anticipated to reach a market value of US$ YY Bn by 2027, witnessing a CAGR of 18.1 % during the forecast period. Key drivers of the market are an increase in the geriatric population along with suitable government policies.
An increasing rate of acute hyperkalemia occurrence coupled with chronic hyperkalemia is through rising geriatric population. Technological advancements are projected to contribute to rising incidents of heart and chronic kidney-related diseases, and related group of patients are projected to take risk related to hyperkalemia are stimulating its market treatment. Thus as per the report from the World Population Prospects: of 2017 Revision, the age group of 60 years and above, are projected to increase during the forecast period.
The Hyperkalemia Treatment market is anticipated to register a CAGR of over 18.1% during the forecast period.
To Have A Glimpse Of The Report Or To Avail The Free Sample Click The Link Below:
By Application, Chronic hyperkalemia treatment segment held a prominent share in Global Hyperkalemia Treatment Market in 2018.
Chronic hyperkalemia treatment is dominating the global market. Chronic hyperkalemia is related to impaired renal excretion. The chronic hyperkalemia is commonly asymptomatic, thus its treatment is through the elimination of general symptoms, cardiac dysrhythmias, and causing death. The treatment of chronic hyperkalemia consists of diuretics, bicarbonate salts, dietary restriction, potassium binders, and dialysis. The chronic hyperkalemia is key complexities involved in chronic kidney disease (CKD) that contributed infrequently and requires significant management of nephrologist. Thus it is supportive to lead the global market during the forecast period.
North America is Anticipated to Dominate the Global Hyperkalemia Treatment Market during the Forecast Period
The North American market is dominating in its position for hyperkalemia treatment through advancement in healthcare technology and increase of geriatric populations are suffering from the heart and kidney diseases are significantly high in the patients who are at risk of hyperkalemia. An estimated 3.7 Mn in the US adults are accounted for hyperkalemia in the year 2014, and its rate of occurrence is greater since 2010. Patients suffering from CKD and other chronic diseases coupled with a rise in the annual growth of hyperkalemia of about 6.34% in 2014, and approximately half of this population suffering from hyperkalemia has chronic heart or kidney diseases. Greater accessibility for medication, rising awareness, with favourable reimbursement is a vital factor fueling its market growth in the North American region.
Global Hyperkalemia Treatment market was moderately consolidated with key players accounting for a significant share in 2018. The companies that are offering innovative products in the treatment of hyperkalemia are increasing their competitiveness in the global market.
Prominent players operating in the Global Hyperkalemia Treatment Market are Ardelyx, Sanofi S.A., AstraZeneca Plc, Vifor Pharma Management Ltd., and Perrigo Company plc., among others.
Impact of COVID-19 on Economy, Industry and Company
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in demand & supply gap, production delay and weak consumer demand of end products across industries.
At Bizizz Market Research, our analyst has done extensive research across industries and identified various methodologies which would assist C-Level executives to counter this ongoing threat and make informed business decisions.
Areas at which Bizizz Market Research would help decision makers are:
a) Insights on current demand & supply gap analysis
b) Impact on value chain and supply chain and strategies adopted to off set its impact
c) Impact on Industry / company revenue and predictive intelligence on forecast sales
d) In-depth analysis on market segmentation – both value and volume analysis
e) Market assessment, regional
and country attractiveness, competitive benchmarking
and entry strategy
f) Prioritizing strategies and
how it would impact company’s short to long-term business
About Bizizz Market Research:
Bizizz Market Research (BMR) is a unique market research, consulting, and business solution organization that offers best strategic and tactical support to customers to enhance their business decision process. BMR team is full of impassioned & dedicated experts who thrives to give their very best to their clients and always ready to take any challenge.
Our expanding team of professionals & experts from a wide array of streams and vertical has critical problem solving skills, innovative approaches and research techniques to deliver best solution to our clients. We continuously pushing our capabilities to enhance our services and setting higher quality goals each day. BMR offers syndicated reports, custom reports and consulting services to our clients. We are capable of catering the market research demands of individuals and organizations of various industries across different geographies with utmost data accuracy in minimal turnaround time.
Bizizz Market Research
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone: +1 408-622-0123
Email : [email protected]
Reference Link: https://www.bizizzmarketresearch.com/pr/global-hyperkalemia-treatment-market
Be First to Comment